D. E. Shaw & Co., Inc. Ideaya Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 308,556 shares of IDYA stock, worth $6.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

308,556

Previous 180,676 70.78%

Holding current value

$6.51 Million

Previous $4.64 Million 8.85%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$16.38 - $26.0 $2.09 Million - $3.32 Million	127,880 Added 70.78%	308,556 $5.05 Million
Q4 2024 Feb 14, 2025	SELL	$24.79 - $31.98 $9.6 Million - $12.4 Million	-387,055 Reduced 68.18%	180,676 $4.64 Million
Q3 2024 Nov 14, 2024	SELL	$30.37 - $43.05 $9.62 Million - $13.6 Million	-316,807 Reduced 35.82%	567,731 $18 Million
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $7.79 Million - $9.84 Million	226,514 Added 34.42%	884,538 $31.1 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $4.4 Million - $6.06 Million	128,518 Added 24.27%	658,024 $28.9 Million
Q4 2023 Feb 14, 2024	BUY	$24.59 - $35.83 $2.29 Million - $3.34 Million	93,148 Added 21.35%	529,506 $18.8 Million
Q3 2023 Nov 14, 2023	BUY	$21.07 - $29.77 $4.7 Million - $6.64 Million	223,143 Added 104.66%	436,358 $11.8 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $1.55 Million - $2.97 Million	116,156 Added 119.68%	213,215 $5.01 Million
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $1.03 Million - $1.42 Million	76,118 Added 363.49%	97,059 $1.33 Million
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $303,016 - $380,497	20,941 New	20,941 $380,000
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $203,605 - $341,309	-24,590 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$11.18 - $24.02 $256,323 - $550,706	-22,927 Reduced 48.25%	24,590 $275,000
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $580,524 - $744,844	27,710 Added 139.9%	47,517 $1.12 Million
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $341,868 - $536,373	19,807 New	19,807 $505,000
Q2 2021 Aug 16, 2021	SELL	$17.76 - $24.83 $342,643 - $479,045	-19,293 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.48 - $23.77 $133,505 - $235,418	-9,904 Reduced 33.92%	19,293 $453,000
Q4 2020 Feb 16, 2021	BUY	$12.17 - $17.52 $355,327 - $511,531	29,197 New	29,197 $409,000

Others Institutions Holding IDYA

# of Institutions

212

Shares Held

80.3M

Call Options Held

80.3K

Put Options Held

30.5K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.01B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account